Exploring Stakeholder Perspectives on the Development of a Gene Drive […]
The Keystone Value
Innovations like gene editing and artificial intelligence have the power to profoundly affect human societies in both positive and negative ways. Early incorporation of diverse societal perspectives into governance for these and other emerging technologies is crucial. Keystone Policy Center fosters inclusive dialogue to anticipate, reflect upon, and respond to the potential risks, benefits and uncertainties of emerging technologies in our complex food, health and ecological systems. Whether the discussion is on heritable human genome editing, genetic or infectious disease, agriculture, or invasive species management, Keystone’s work focuses on issues central to responsible innovation: equity, ethics, sustainability, transparency, accountability, control and access, risk assessment and management, and stakeholder engagement.
Keystone Highlights
Public Debate and the Future of Genome Editing in Human […]
Control and Access: Intellectual Property and CRISPR-Cas Gene Editing for […]
Stakeholder Engagement Practices to Inform the Development of Area-wide Vector […]
Health and CRISPRcon The scientific community has handed the world […]
NGOs Outline Principles for Governance of Gene Edited Products for […]